Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Huanglianjiedu Decoction as an effective treatment for oral squamous cell carcinoma based on network pharmacology and experimental validation

Fig. 6

The effects of HLJDD (HLJDD 5 mg/mL, HLJDD 2.5 mg/mL, HLJDD 1.25 mg/mL), paclitaxel 6 μg/mL and cisplatin 5 μg/mL on cell cycle. Cell cycle histograms determined by CytoFLEX LX flow cytometry analyzer following Ethidium Bromide (EB) staining. SCC-25 cells were treated with HLJDD 5 mg/mL, HLJDD 2.5 mg/mL, HLJDD 1.25 mg/mL, paclitaxel 6 μg/mL and cisplatin 5 μg/mL for 24 h. *** p < 0.001, **p < 0.01, * p < 0.05 vs. control group. ### p < 0.001, ## p < 0.01, # p < 0.05 vs. paclitaxel group. $$$ p < 0.001, $$ p < 0.01 vs cisplatin group. n = 3

Back to article page